Qualigens Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.55 Cr
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 37.99 Cr
- Revenue Growth 45.61%
- Profit Growth 26.63%
- Ebitda 37.14%
- Net Worth 35.31%
- Total Assets 25.08%
About Qualigens Pharma
Qualigens Pharma Private Limited (QPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 October 2013 and has a history of 11 years and three months. Its registered office is in Khalapur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.55 Cr.
The company currently has active open charges totaling ₹37.99 Cr.
Company Details
-
Location
Khalapur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2013PTC249071
-
Company No.
249071
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Qualigens Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Jain
|
Director | 10-Mar-2016 | Current |
|
Aayush Jain
|
Director | 01-Aug-2017 | Current |
|
Ankit Paharia
|
Director | 10-Oct-2013 | Current |
Financial Performance of Qualigens Pharma.
Qualigens Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.61% increase. The company also saw a substantial improvement in profitability, with a 26.63% increase in profit. The company's net worth Soared by an impressive increase of 35.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qualigens Pharma?
In 2023, Qualigens Pharma had a promoter holding of 0.65% and a public holding of 99.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kopran Lifesciences LimitedAjit Jain is a mutual person
-
Naulakha Impex LlpAjit Jain and Aayush Jain are mutual person
-
Jinendra Qualipharm Private Limited
Ajit Jain and Aayush Jain are mutual person
-
Vakunth Vinimay Llp
Aayush Jain is a mutual person
-
Bulwark Business Services Llp
Aayush Jain and Ankit Paharia are mutual person
-
Ajaayu Trading And Consultancy Private Limited
Aayush Jain is a mutual person
Charges (Loans)
₹37.99 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 26.99 Cr
- Axis Bank Limited : 11.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2021 | Axis Bank Limited | ₹11.00 Cr | Open |
| 27 Feb 2020 | Others | ₹2.24 Cr | Open |
| 17 Jul 2019 | Others | ₹24.75 Cr | Open |
How Many Employees Work at Qualigens Pharma?
Qualigens Pharma has a workforce of 226 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qualigens Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualigens Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
